A recent study from Oregon State University has revealed a promising approach to treating glioblastoma, one of the most aggressive forms of brain cancer.
This cancer is known for its particularly low survival rate, with less than 30% of patients surviving beyond two years.
The discovery of sugar-coated nanoparticles may offer new avenues for therapy, though further research will be necessary to assess its efficacy and safety.